MENU
+Compare
NSPR
Stock ticker: NASDAQ
AS OF
Jun 2, 01:01 PM (EDT)
Price
$2.50
Change
-$0.06 (-2.34%)
Capitalization
55.59M

NSPR InspireMD Forecast, Technical & Fundamental Analysis

InspireMD Inc is a United States based medical device company... Show more

NSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NSPR with price predictions
May 30, 2025

NSPR's Stochastic Oscillator is sitting in overbought zone for 2 days

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 50-day moving average for NSPR moved below the 200-day moving average on May 06, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NSPR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NSPR's RSI Oscillator exited the oversold zone, of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on May 28, 2025. You may want to consider a long position or call options on NSPR as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NSPR just turned positive on May 27, 2025. Looking at past instances where NSPR's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

NSPR moved above its 50-day moving average on May 29, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NSPR advanced for three days, in of 217 cases, the price rose further within the following month. The odds of a continued upward trend are .

NSPR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 151 cases where NSPR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.405) is normal, around the industry mean (24.191). P/E Ratio (0.000) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (9.259) is also within normal values, averaging (42.393).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NSPR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NSPR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
NSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NSPR is expected to report earnings to fall 4.55% to -20 cents per share on August 12

InspireMD NSPR Stock Earnings Reports
Q2'25
Est.
$-0.21
Q1'25
Beat
by $0.09
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.04
Q2'24
Missed
by $0.03
The last earnings report on May 09 showed earnings per share of -21 cents, beating the estimate of -31 cents. With 6.63K shares outstanding, the current market capitalization sits at 55.59M.
A.I. Advisor
published General Information

General Information

a developer of medical devices

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
4 Menorat Hamaor Street
Phone
+972 36917691
Employees
66
Web
https://www.inspiremd.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SG13.420.66
+5.17%
Sweetgreen
ANET86.640.27
+0.31%
Arista Networks Inc
ANIK11.15-0.11
-0.98%
Anika Therapeutics
SSB87.80-1.07
-1.20%
SouthState Corp
AGFY27.52-1.68
-5.75%
Agrify Corporation

NSPR and Stocks

Correlation & Price change

A.I.dvisor tells us that NSPR and CORBF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NSPR and CORBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NSPR
1D Price
Change %
NSPR100%
N/A
CORBF - NSPR
26%
Poorly correlated
N/A
EW - NSPR
24%
Poorly correlated
+0.63%
MLSS - NSPR
23%
Poorly correlated
-3.40%
RSLS - NSPR
23%
Poorly correlated
+8.15%
ATRC - NSPR
23%
Poorly correlated
+1.44%
More